This inventor holds 1 USPTO granted patent. Top assignee: University of Alberta. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: John K. Buolamwini and His Nucleoside Transporter Invention.
Introduction
John K. Buolamwini is an inventor associated with the University of Alberta in Edmonton, Canada. His patent work includes a method and probes for detecting nucleoside transporters in animal cells.
Latest Patents
The supplied information identifies one patent for Buolamwini: “Method and Probes for Detecting Nucleoside Transporter and Method for.” The invention describes compounds designed to bind to the es nucleoside transporter of animal cells. Its claims define a range of chemical structures and substituents, including variations in ring atoms, alkyl and heteroalkyl groups, and functional groups such as halogens, hydroxyl groups, and azides. These compounds are intended to support the detection and study of nucleoside transporters.
Career Highlights
Buolamwini’s listed patent reflects research at the intersection of chemistry and cellular biology. The invention’s focus on transporter-binding compounds offers tools for investigating how nucleosides move across animal-cell membranes. The supplied record attributes 1 patent to him.
Collaborations
The information provided associates Buolamwini with the University of Alberta and names James S. Wiley and James D. Craik as coworkers. Their inclusion points to a research environment involving expertise relevant to the patent’s biological and chemical subject matter.
Conclusion
John K. Buolamwini’s documented invention centers on compounds and probes for detecting nucleoside transporters, representing a focused contribution to research tools in cellular biology and chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
